Medicamen Biotech Revenue

In the fiscal year ending March 31, 2025, Medicamen Biotech had annual revenue of 1.63B INR, down -9.35%. Medicamen Biotech had revenue of 296.13M in the quarter ending March 31, 2025, a decrease of -37.42%.

Revenue

1.63B

Revenue Growth

-9.35%

P/S Ratio

3.25

Revenue / Employee

4.30M

Employees

378

Market Cap

5.28B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	1.63B	-167.59M	-9.35%
Mar 31, 2024	1.79B	384.39M	27.29%
Mar 31, 2023	1.41B	254.22M	22.02%
Mar 31, 2022	1.15B	27.29M	2.42%
Mar 31, 2021	1.13B	-128.18M	-10.21%
Mar 31, 2020	Pro	Pro	Pro
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Sun Pharmaceutical Industries	525.78B
Divi's Laboratories	93.60B
Cipla	272.67B
Apollo Hospitals Enterprise	217.94B
Zydus Lifesciences	232.42B
Mankind Pharma	122.07B
Aurobindo Pharma	317.24B
Fortis Healthcare	77.83B

Revenue Rankings

Medicamen Biotech News

24 days ago - Medicamen Biotech secures USFDA nod for Bortezomib injection, marks its first ANDA approval - Business Upturn
3 months ago - Medicamen Biotech shares surge 8% after signing contract for CDMO with XGX pharma - Business Upturn
4 months ago - Medicamen Biotech expands into South Africa after EU approval, eyes $4 billion pharmaceutical market - Business Upturn
4 months ago - Medicamen Biotech shares jump 3.50% after signing long-term manufacturing deal for US and Europe - Business Upturn
4 months ago - Medicamen Biotech secures 10-year manufacturing and supply deal with leading US pharma distributor - Business Upturn

More News